Incidence and Predictors of Implantable Cardioverter-defibrillator Therapies After Generator Replacement—A Pooled Analysis of 31,640 Patients’ Data

Among primary prevention implantable cardioverter-defibrillator (ICD) recipients, 75% do not experience any appropriate ICD therapies during their lifetime, and nearly 25% have improvements in their left ventricular ejection fraction (LVEF) during the lifespan of their first generator. The practice...

Descripción completa

Detalles Bibliográficos
Autores principales: Khanra, Dibbendhu, Manivannan, Subha, Mukherjee, Anindya, Deshpande, Saurabh, Gupta, Anunay, Rashid, Wasim, Abdalla, Ahmed, Patel, Peysh, Padmanabhan, Deepak, Basu-Ray, Indranill
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MediaSphere Medical 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246925/
https://www.ncbi.nlm.nih.gov/pubmed/37293556
http://dx.doi.org/10.19102/icrm.2022.13121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246925/
https://www.ncbi.nlm.nih.gov/pubmed/37293556
http://dx.doi.org/10.19102/icrm.2022.13121

Ejemplares similares